GlaxoSmithKline (GSK) Consumer Nigeria Plc says it intends to stop tasks in the wake of assessing the choices for moving to an outsider conveyance model for its drug items.

The organization is notable for its items like Augmentin, Neosporin, Panadol, Sensodyne, Advair, Ventolin, Theraflu, among others.

GSK Nigeria reported the improvement in a proclamation shipped off the Nigeria Exchange Limited (NGX) on Thursday and endorsed by Frederick Ichekwai, the organization secretary.

The organization said it is working with its counsels to settle on following stages and plans to present a plan of plan to the Securities and Exchange Commission (SEC), which whenever supported, will see it return money to investors with the exception of its parent organization, GSK UK.

The organization, which utilizes more than 290 individuals, guaranteed that all vital legal actions would be met with respect to representatives and investors.

‘In our distributed Q2 results we unveiled that the GSK UK Gathering has educated GlaxoSmithKline Purchaser Nigeria PLC regarding its essential expectation to stop commercialization of its physician endorsed medications and immunizations in Nigeria through...Read More.

The Story is not Complete. Why did they do that?? Did they went Bankruptcy in Nigeria 🤔🤔

Making a way for Agbado to dominate.

Haaaa

This is the few foreign companies that Is still operating in this harsh economic conditions.Tinubu travel out before his inauguration to go and beg foreign investors to come to Nigeria, meanwhile,the ones who are already here are preparing to leave because of bad governance.